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ABSTRACT
Listeria monocytogenes is an ubiquitous Gram-positive food borne pathogen.
Ingestion of L. monocytogenes contaminated food can cause serious infections in
immune-compromised persons. In addition to planktonic growth, this pathogen can also
grow as biofilms under adverse conditions, which has been proved to be more resistant
than its planktonic counterpart to various eradications, such as antibiotic treatments.
Compared with the extensively studied intracellular replication mechanisms, L.
monocytogenes biofilm developmental process is not well understood.
Our research group initiated a systemic study on the molecular mechanisms of L.
monocytogenes biofilm formation. A whole genome-scale screening for functional factors
involved in L. monocytogenes biofilm development was carried out by means of
transposon mutagenesis in combination with microtiter plate assays. 14 mutants with an
at least 50% decreased biofilm formation were selected from 10,000 transposon mutants.
Transposon locations in these 14 mutants were identified through NEST-PCR and
sequencing. The in-frame deletion mutant of two genes, lmo2553 and lmo2554, were
generated and showed similar biofilm formation defects as the transposon mutant. The
roles of these genes in L. monocytogenes biofilm development will be further pursued in
the future.
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CHAPTER ONE
INTRODUCTION
Listeria monocytogenes, an ubiquitous Gram-positive food borne pathogen, has a
wide distribution in the natural environment like water or soil, and is frequently
associated with food contamination. As the etiological agent of listeriosis, its intracellular
surviving mechanisms, which are primarily governed by the master transcriptional
regulator PrfA[1-3], have been relatively well explored. It’s been proven by different
groups that L. monocytogenes is biofilm formation capable as well. As known, biofilm is
a special microbial community that attaches to either biotic or abiotic surfaces and grows
as a coordinated sessile community. Extracellular polymeric substance (EPS) plays an
important role in the maintainance of the complex biofilm structure. Compared with its
planktonic counterpart, biofilm is more resistant to various environmental stress, such as
antibiotic treatment, nutrient limitation, and physical elimination. This could be a serious
problem for those frequently involved in food contamination while at the same time are
biofilm-capable, such as L. monocytogenes. Since L. monocytogenes is a frequent foodassociated pathogen, during food processing, it has various access to attach to certain
surfaces, for example, plastic containers or stainless steel benches, and develop biofilm.
Once occured this will significantly increase the survival of this pathogen and pose a
hazardous threatening of food safety.
Currently the developmental process of L. monocytogenes biofilm is not well
understood. Some factors have been shown to be involved but the detailed functions and
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regulatory networks still await elucidation. A better understanding about the molecular
mechanisms adopted by this pathogen in biofilm growth will help with the identification
of critical factors in this developmental process and potential targets for elimination of
biofilm contamination. This could be beneficial for both researches focused on L.
monocytogenes and industrial issues bothered by biofilm contamination.
This study attempted to address the molecular basis of L. monocytogenes biofilm
formation by starting with a genome-wide screening for functional factors involved in
biofilm development. Transposon mutagenesis was utilized in combination with
microtiter plate assays. 14 mutants were selected from a total of 10,000 transposon
mutants with an at least 50% decreased biofilm formation. The transposon location in
these 14 mutants were identified through NEST-PCR and sequencing. The in-frame
deletion mutant of two genes, lmo2553 and lmo2554, were constructed and the biofilm
test showed that both have the similar biofilm defect as the transposon mutant.
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CHAPTER TWO
LITERATURE REVIEW
Influences of Listeria monocytogenes as a food born pathogen
As an ubiquitous Gram-positive bacterium, L. monocytogenes exists almost
everywhere in our environment. It is such a well-adapted bacterium that it can not only
survive vigorously as saprophyte in animal feces or acid mine drainage, but also as
intracellular pathogen in various mammalian hosts. It is able to cause serious infections in
the newborns, elders, pregnant women and the immune-compromised people. As the
etiological agent of listeriosis, it can cause meningoencephalitis, septicemia, placentitis,
abortion, neonatal septicemia, febrile gastroenteritis and subclinical pyogranulomatous
hepatitis[4]. 2500 cases of listeriosis occur annually in the US, among which 500 cases
result in death[5]. L. monocytogenes is also a food-borne pathogen that is frequently
associated with world-wide outbreaks and is under CDC surveillance. A lot of different
types of food can serve as prosperous niches for this pathogen, such as dairy
products[6,7], meat[8], and sea food[9]. The contamination of this pathogen in food has
always been a concern in the food industry, probably due to its highly evolved ability to
survive unfavorable conditions. L. monocytogenes can replicate at 1°C[10], which is the
refrigeration temperature for most refrigerated food, and it can survive over a pH range
from 4.4 to 9.4[10], or in an environment with a water activity as low as 0.92[10]. These
characteristics all contribute to its increasing chances to cause human infections.
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Contamination by L. monocytogenes can become a big economic concern as well,
especially for food industry. There was a big recall of imported Manouri Cheese recently
due to potential L. monocytogenes contamination[11]. Recalls of various products, such
as sliced smoked salmon[12] and sprouts[13] were also associated with L. monocytogenes
contamination. All these recalled products should be destroyed, and this could be a big
economic loss for the company.
Listeria monocytogenes PrfA regulon
As a model organism for the study of intracellular pathogenicity, the parasitic
mechanisms of L. monocytogenes were extensively explored. The development of various
genetic tools in the recent 30 years has facilitated the study of pathogenesis of this highly
mortal pathogen[14-20]. The availability of genomic sequences of several strains
dramatically accelerated the L. monocytogenes functional research[21]. L. monocytogenes
pathogenicity is mainly mediated by the Listeria Pathogeneity Island-1 (LIPI-1) (Figure
2-1), the expression of which is precisely regulated by the master transcriptional factor
PrfA[1-3]. The adaptation from a saprophyte to an intracellular pathogen requires the
activation of PrfA and the subsequent induction of virulence factors[1,4,22,23].

Figure 2-1. Genetic scheme of L. monocytogenes Pathogenecity Island-1. The symbol
represents the terminator.
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Figure 2-2. Intracellular life cycles of L. monocytogenes[28].
As depicted in Figure 2-2, the intracellular life cycles of L. monocytogenes can be
generally summarized into four stages. The first stage is the invasion of host cells, and for
non-professional phagocytic cells this step is mediated by two bacterial surface proteins,
internalin A (InlA) and internalin B (InlB)[24,25]. Upon entering the cytoplasm, the
bacterium will be entrapped in a membrane-defined compartment called vacuole[4,22]. A
successful intracellular infection will require the bacterial escape from the vacuole, which
is the second stage of intracellular infection, by the function of bacterial hemolysin
Listeriolysin O (LLO) and phospholipases[4]. Then bacterium will proceed to the third
stage, which is cytosolic replication using all the nutrients from the cytosol. The fourth
stage, cell-to-cell spread is mainly mediated by ActA protein, which plays a central role
in the recruitment of host cell actin protein to generate the actin tail and enable the
bacterium to move intracellularly[4,26,27]. A double-membrane vacuole is formed upon
the invasion of the adjacent cell and the bacterium will repeat another intracellular life
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cycle. This direct transmission among the host cells protects the bacterium from
encountering the humoral immunity effector cells and molecules and increases the chance
of successful infection.
All the aforementioned virulence proteins are members of the PrfA regulon, under
control of the positive regulatory factor PrfA, the gene of which is also located on the
LIPI-1 downstream of the gene plcA (Figure 1-1). This 27 kDa protein belongs to the
Crp/Cap regulatory protein family[29] and shares structural similarities with the
enterobacterial regulator Crp (cAMP receptor protein). PrfA functions as a homodimer to
bind to a palindromic promoter element tTAACanntGTtAa, named PrfA box[1], via the
C-terminal helix-turn-helix (HTH) DNA binding motif. The monomer interaction occurs
through the N-terminal domain including a β-roll and a long α-helix. Binding of this
transcriptional activator will recruit the RNA polymerase to the targeted promoter region
and initiate transcription[24]. PrfA was generally considered as essential for L.
monocytogenes parasitism because prfA deletion mutants have been shown to be totally
nonpathogenic due to the inability of virulence genes induction[24]. But a recent study on
a low-virulence strain A23 did find that even without functional major virulence factors,
such as the metalloprotease Mpl, internalin A, internalin B, and phospholipases, the strain
could still form plaques and contaminate 100% of inoculate mice[30]. This indicates that
this A23 strain might partially keep its virulence by some unidentified mutations[30].
PrfA regulation is well manipulated by L. monocytogenes at transcriptional, posttranscriptional, and post translational levels[24]. Regulation at post translational level
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mainly occurs through the changes of PrfA binding activity[1]. PrfA in the saprophytes
normally exists in a native form which is weakly active, while binding to the unknown
cofactor in the host cell will turn PrfA into the fully activated state[1]. Lots of study
about various PrfA* mutants, such as Gly145Ser[31,32], Ile45Ser[33], Gly155Ser[34],
Leu140Phe[35] and Glu77Lys[34], do prove that by mutation of specific amino acid
outside of the HTH motif, PrfA can be locked on the highly active conformation and
induce the PrfA-dependent virulence expression to a similar high level observed in the
intracellular infection. In contrast, mutation inside the HTH motif significantly decreases
the DNA binding affinity and leads to a loss of virulence[36]. In addition to this positive
activating pathway, negative regulatory pathways have been found as well. One obvious
evidence is the activated charcoal effect. It was well observed that adding activated
charcoal to the culture medium can dramatically stimulate the virulence genes
expression[37], and the adsorption of an unknown diffusible autorepressor by the
activated charcoal was suspected to mediate this phenomenon. The other evidence of
negative regulation is the observation that expression of virulence genes are
downregulated in glucose or fructose supplemented medium even in the presence of
activated charcoal[38-40]. This might suggest independent pathways for the sugarmediated regulation and autorepressor-mediated regulation.
It was well proven that prfA can be transcribed as both monocistronic and
bicistronic[42,43]. Two promoters, PprfAP1 and PprfAP2, as shown in Figure 2-3, exist in
the intergenic region between prfA and plcA. PprfAP1 is a σA-dependent promoter which
is responsible for the low level PrfA synthesis in the normal environmental setting
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bacteria[1], while PprfAP2 can be regulated by both σA and σB and mainly mediates the
elevation of virulence expression under stress conditions[1,44]. The 5’ untranslated
region (UTR) of transcripts generated from PprfAP1 promoter can form a secondary
structure at low temperature such as 30°C to work as a thermosensor[45]. This secondary
structure will only melt at high temperature, for example 37°C which is the normal
human body temperature, and reveal the ribosome binding site at the 5’ UTR for PrfA
translation. This might partially explain the rapid PrfA-dependent virulence induction
upon host infection. prfA can also be transcribed as a bicistronic transcript from the PplcA
(Figure 2-3), and since PplcA is PrfA-dependent, it has a positive feedback on PrfA
synthesis.

Figure 2-3. The organization of the three promoters that control the prfA transcription[41].
Square labeled A represents the recognition site for σA factor, and square labeled B
represents the recognition site for σB factor.
Distinctive PrfA binding affinity to different promoters could be another way to
manipulate PrfA regulation. More PrfA are required for activation of those promoters
with mismatches in the PrfA box than those exactly matched promoters[46,47]. And the
RNA polymerase (RNAP) binding affinity of the promoters could also plays a role in the
expression regulation of the PrfA-dependent virulence genes[1].
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As the master regulator of L. monocytogenes, PrfA was considered as the critical
regulator that mediates the transition from the extracellular free-living motile life style to
the intracellular pathogen. But a very recent study from Kolter’s group just provided solid
evidence for the idea that PrfA also contributes to biofilm formation, and is involved in
the transition from the extracellular free-living style to the biofilm style[41]. prfA mutants
were defective in biofilm formation after initial surface adhesion[41], and the PrfA
conformational change for biofilm formation is different from those required for
intracellular virulence expression[41]. It would be interesting to investigate the molecular
mechanisms of PrfA biofilm promotion.
Bacterial biofilms
Biofilm is generally considered as an aggregate of microbial cells that attaches to
either biotic or abiotic surfaces and grows as a matrix-encased community. Naturally
occurred biofilm usually consists of mixed species populations, and this provides the
growing community two advantages, a reciprocal balance in the whole community when
the nutritional condition is altered due to the different physiological metabolism
properties of the mixed population [48], and increased overall biofilm fitness due to the
cooperation between these species through their various properties in cellular attachment,
matrix synthesis, dispersal, motility and toxin production[48]. Both Gram-negative and
Gram-positive bacteria, including L. monocytogenes, have been shown to be capable of
biofilm growth on the surfaces of various materials.
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Through detailed study of biofilm development of various bacteria, a general fivestep developmental process has been proposed to govern the most bacterial biofilm
formation[49].The first step is the initial attachment of single cells, which usually is
reversible and followed by the second step of irreversible attachment and beginning of
extracellular polymeric substance (EPS), or the so-called matrix production. The
mechanisms and mediators of the cell attachment have been a focus of biofilm research
for a long time, and one good example is the role of flagellum. Flagellum was generally
considered as required for initial cell attachment in E. coli[50], P. aeruginosa[51], and L.
monocytogenes[52,53], although evidences of its inhibitory effect on cellular attachment
were also found by other group[54], and whether it serves as a adhesion molecule or
motility factor is still under debation. As the matrix production continues and the matrix
accumulates, the biofilm architecture begins to establish in the third step, and then
become mature in the fourth step. The matrix plays an important role in the maintenance
of the biofilm structure[55]. Proteins, exopolysaccharides, lipids, and nucleic acids have
been identified as components of the extracellular matrix while their relative contribution
to the whole community might vary among different species[49]. In L. monocytogenes,
proteins[56] and extracellular nucleic[57] acids were identified to be two components of
its biofilm matrix. Due to the importance of matrix in biofilm, enzymes such as
glycosidases, proteases, or deoxyribonucleases that can degrade biofilm matrix have been
proposed as potential methods to control or eliminate biofilm growth[58]. Studies with
scanning confocal laser microscopy (SCLM) revealed that generally the sessile bacteria
grow in matrix encased clusters which are separated by a network of open water channels
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for the purpose of nutrient exchange[49]. While some species biofilms exhibit a
mushroom-like 3D structure[49], L. monocytogenes biofilm shows a different type that
consists a network of knitted chains[59]. Finally, cell dispersion is shown to be an
important and regulated step in the homeostasis of the biofilm community[49]. It was
recently reported that in P. aeruginosa, as the biofilm structure becomes mature, matrixfree cavity would be formed inside the clusters and swimming cells will be released from
this cavity at the dispersion stage[60]. This self-active dispersal process called
seeding[58], is one of the three distinct modes of biofilm dispersion[58], the other two
types including erosion, which usually refers to continuous release of small clusters of
cells from the biofilm, and sloughing, which defines the sudden detachment of large
portions of the biofilm[58].
Biofilm has been proposed as an integral phase of bacterial life cycle which is
usually adopted when the bacteria confront unfavorable living conditions. It’s been
extensively demonstrated that compared with its planktonic counterpart, biofilm is much
more resistant to the environmental stress, such as nutritional limitation, antibiotic[61],
detergent treatment[62], or organic acids treatment[63]. In addition to functioning as the
penetration obstacle attributing to its complex architecture[49], the strategies adopted by
this sessile group for increased antibiotic resistance have been revealed to include several
conventional mechanisms, for example, chromosomal β-lactamase, up-regulated efflux
pumps, and mutations in the antibiotic target molecules[64].
Transcriptional regulation in biofilm development
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In Bacillus subtilis, the most thoroughly studied Gram-positive organism and also
the close relative of L. monocytogenes, several transcriptional factors (Figure 2-4) have
been revealed to affect the bacterial biofilm formation, especially in terms of the matrix
production, through the precise regulation of their downstream genes expression. The
main matrix components of B. subtilis biofilm are encoded by two operons, the 15-gene
eps operon which encodes the enzymes involved in exopolysaccharides production[65],
and the yqxM-sipW-tasA operon[66] which encodes the secreted matrix protein TasA.
The eps operon and the tasA operon are both repressed by SinR[67], the master regulator
for B. subtilis biofilm, and this repression is released by the interaction of SinR with the
anti-repressor SinI[68]. While under normal conditions SinR is constitutively expressed
in the bacterial community, SinI is under the positive control of Spo0A bistable
switch[68]. Two other regulators, AbrB and Sigma H factor, are also involved in B.
subtilis biofilm transcriptional regulation. AbrB works as a negative regulator for biofilm
formation by repressing the expression of one putative secreted protein YoaW and the
signal peptidase SipW[69], while AbrB expression is under the direct negative control of
Spo0A [70]. In contrast, Sigma H factor is suggested to indirectly stimulate the biofilm
formation by activation of Spo0A expression[69,71]. A recent interesting observation
found that expression of the anti-repressor SinI will be turned on only in a subpopulation
of the B. subtilis biofilm community, thus the derepression of yqxM-sipW-tasA operon
and eps operon in this subpopulation actually provides matrix for the whole biofilm
community[68]. This labor-division system enables the B. subtilis cells to incorporate
various environmental signals, such as nutritional or stress signals, to coordinate various
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physiological processes, such as sporulation, cannibalism and biofilm formation[72],
through this complex regulatory network and provide itself the best survival strategy.

Figure 2-4. The transcriptional regulation network in B. subtilis biofilm.
In L. monocytogenes, currently only one transcriptional regulator, DegU, has been
directly proven to mediate biofilm formation. L. monocytogenes DegU is an orphan
response regulator which binds to its own promoter and works as an auto-represser[73]. It
also binds to the promoter of motB operon and positively regulates the expression of
GmaR[73], which is the anti-repressor of flagellar synthesis. DegU plays a role in
bacterial motility, chemotaxis, virulence and biofilm of several Gram positive
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species[73,74]. Deletion of DegU led to reduced L. monocytogenes biofilm formation[73]
and its indirect regulation on flagella was suggested to mediate its role in biofilm[75].
Considering the involvement of flagella in L. monocytogenes biofilm[52], it would be
tempting to look at if some other factors, such as MogR which has been shown to
regulate flagellum motility[76] and virulence[77], also has a role in biofilm formation.
Further study on biofilm matrix might provide more hints to unravel the transcriptional
regulation network of L. monocytogenes biofilm.
Quorum sensing in biofilm
Quorum sensing (QS) generally refers to the bacterial inter-species or intra-species
communication based on the population-dependent production and secretion of certain
diffusible small compounds. The accumulation of these signal molecules would be
detected when it reaches a threshold, and stimulates the cellular responses in forms of
regulated gene expression and coordinated population behavior. Quorum sensing has
been found in both Gram-positive and Gram-negative bacteria. Different types of
molecules function as the “language”, and this communication actually mediates various
physiological processes including bacterial pathogenesis[78], bacteriocin production[79],
competency development[80], biofilm formation[81,82] and multidrug resistance[83,84].
In the Gram-positive Streptococcus pneumonia, the broadly studied competence
signaling peptide (CSP) QS system was demonstrated to influence the biofilm growth[82].
CSP is an oligopeptide product of the com regulon. comA and comB encode the secretion
apparatus for CSP, while comC encodes the CSP precursor. The accumulated CSP is
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detected by ComD, a surface histidine kinase receptor for CSP, and the signal is
transmitted through the response regulator ComE, which induces the com regulon[85].
The subsequent product ComX is a sigma factor that regulates the expression of several
groups of downstream genes[86]. Initially the CSP QS was found to affect bacterial
competence. Accumulation of CSP to the threshold stimulates a subpopulation of the
bacterial community to lyse and release nucleic acid, which is taken up by the remaining
cells[87]. Addition of CSP increases the DNA level in the matrix as well as the biofilm
growth[88,89]. Considering the role of nucleic acid as a component of biofilm matrix, it
was suspected that the effects of CSP on biofilm growth could be related with its
induction of cell lysis and DNA release[90]. But the details of the coordination of these
two distinct yet correlated bacterial population behaviors still await elucidation.
Acylhomoserine lactone (AHL), also known as autoinducer-1 (AI-1)[91], is one
QS signal that is only found in the Gram-negative microorganisms currently. LuxI and
LuxR mediate this AHL QS system. LuxI is the AHL synthase while LuxR is the
cytoplasmic receptor for AHL and at the same time the transcriptional activator for
downstream target genes[92]. When the cell density is low, AHL production level is low
as well and not enough AHL can diffuse into the cytoplasm and bind to LuxR, thus the
unstable LuxR will be degraded. Only when the cell density reaches a certain high level,
AHL will be accumulated to a concentration high enough to bind to LuxR and stabilize as
well as activate the downstream gene expression[92]. It was recently found that among
the many operons affected by AHL, one is the rhlAB which controls rhamnolipids
production[93]. Changes of rhamnolipids production by rhlAB mutation resulted in
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dramatically altered biofilm structure from a mushroom-like to a flat, undifferentiated
one[94]. This AHL QS system controls the bacterial colonization of eukaryotes[95], and
is critical for successful interaction of Pseudomonas aeruginosa with the animal or plant
tissues[96]. Absence of AHL results in decreased biofilm formation in Pseudomonas
aeruginosa[97] and Yersinia pestis[91], and the homologous QS system in Pantoea
stewartii was proven to affect biofilm formation by controlling the exopolysaccharide
production and the cell adhesion[92].
Another broadly studied QS signal is the Autoinducer 2 (AI-2) that exists in both
the Gram-positive and Gram-negative microorganisms[98-101]. AI-2 was initially
discovered in Vibrio harveyi as the quorum sensing molecule to regulate
bioluminescence[102]. AI-2 refers to the collection of cyclic derivatives of 4,5dihydroxy-2,3-pentanedione (DPD), which is a highly reactive metabolic by-product of
the activated methyl cycle[103]. DPD production depends on two catalytic enzymes, Pfs
and LuxS[104]. Pfs catalyzes the conversion of s-adenosyl homocysteine (SAH) into sribosyl homocysteine (SRH), and LuxS catalyzes the conversion of SRH into DPD[104].
While this luxS-dependent AI-2 QS system has a negative regulation on the biofilm
formation of Bacillus cereus and Staphylococcus epidermidis[98,99], it was reported to
positively regulate Streptococcus mutans biofilm formation[105]. It also mediates the
increase of Streptococcus anginosus biofilm in the presence of sub-MICs of
antibiotics[103], and Streptococcus gordonii biofilm formation ability in a mixed-species
environment with Porphyromonas gingivalis[106]. In L. monocytogenes biofilm, LuxS
seems to play a negative role because deletion of LuxS leads to a denser biofilm[104,107].
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But addition of AI-2 molecules couldn’t restore the normal biofilm level. Instead,
addition of the SRH was able to modify the biofilm growth[104]. The role of AI-2 in L.
monocytogenes was suggested to limit to detoxification of SAH, and might be irrelevant
to QS[104].
In L. monocytogenes, one quorum sensing system that has been shown to be
involved in biofilm formation is the agr system. This system is encoded by a four-gene
operon which contains a two-component regulatory system by coding the histidine kinase
AgrC and response regulator AgrA, a signal peptide AgrD and the enzyme AgrB
involved in AgrD processing[108]. High level of signal peptide AgrD due to increased
cellular population enables AgrD to bind to the histidine kinase AgrC, which activates the
response regulator AgrA by phosphorylation[109]. Activated AgrA then turns on the
regulation of the downstream genes, which currently are unclear in L. monocytogenes.
The agr system plays a role in both S. aureus[110] and L. monocytogenes[108,111]
biofilm. Deletion of the signal peptide AgrD or response regulator AgrA resulted in
decreased biofilm, and the agr operon expression level change appeared during the
biofilm development did not happen to the planktonic growth[108].
Considering the broad involvement of QS in biofilm formation, QS has been
studied for its potential as the biofilm eradication target. Inhibitors and antagonists of the
QS were evaluated for their possible effects and consequences on the whole community
as well as individual cell[112].
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CHAPTER THREE
MATERIALS AND METHODS
Strains, plasmids, oligonucleiotides and growth conditions
Strains, plasmids and oligonucleotides used in this study are listed in Table 3-1, 3-2
and 3-3. E. coli was cultured in Luria-Bertani broth (LB) (Bacto, USA) at 37°C with
vigorous shaking unless otherwise specified. Planktonic L. monocytogenes was cultured
in Brain Heart Infusion medium (BHI) (Bacto, USA) at 37°C with vigorous shaking
unless otherwise specified. L. monocytogenes biofilm were grown in LB medium or
Hsiang-Ning Tsai medium (HTM) [113] at 37°C without shaking unless otherwise
specified. In E. coli, 100 µg/ml ampicillin was used to select for ampicillin resistance, 25
µg/ml chloramphenicol was used to select for chloramphenicol resistance, and 30 µg/ml
kanamycin was used to select for kanamycin resistance. In L. monocytogenes, 200 µg/ml
streptomycin was used to select for streptomycin resistance, 5 µg/ml erythromycin was
used to select for erythromycin resistance, and 10 µg/ml chloramphenicol was used to
select for chloramphenicol resistance.
Determination of biofilm growth conditions
Bacterial overnight cultures were grown in 200 µl BHI medium in 96-well
polystyrene plates at 37°C without shaking, then 5 µl of the overnight culture was
transferred to 200 µl HTM or LB medium in 96-well polystyrene plates to grow biofilm.
Biofilm cultures were incubated at either 37°C or 30°C without shaking for 24 h, 48 h or
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72 h. For the biofilm test, the supernatant cultures were discarded and each well was
washed with 250 µl PBS for 5 times. 210 µl of 1% crystal violet was added to each well
to stain the attached cells for 1 h, followed by distill water wash for 5 times. Then 220 µl
of 95% ethanol was added to each well and incubated at room temperature for 6 h. The
absorbance of the ethanol solution at 570 nm was measured using the MULTISCAN EX
plate reader (Thermo, PA, USA).
Transposon mutagenesis
The competent cells of L. monocytogenes were prepared as follows. A 10 ml
overnight culture of L. monocytogenes strain 10403S was grown in BHI at 37°C with
vigorous shaking. Then 3 ml of the overnight culture was inoculated into 100 ml
sucrose/BHI. The freshly inoculated culture was grown at 37°C with vigorous shaking
until the OD.600 reaches 0.2. Then 100 µl penicillin G (10 mg/ml) was added to the
culture, and the incubation was continued for 2 h more. Then the bacterial culture was
centrifuged at 7000 rpm for 10 min at 4°C. After decanting the supernatant, the cell pellet
was washed 3 times with the ice cold wash solution (1 mM HEPES/0.5M sucrose), once
with 100 ml and twice with 50 ml. Finally the cells were resuspended in 250 µl of the ice
cold wash solution (1 mM HEPES/0.5M sucrose), and flash frozen in 100 µl aliquots at 80°C.
The transposon mutagenesis was performed as follows. 0.2 µg transposon plasmid
pMC38[114] was used for the electrophoration of 100 µl 10403S competent cells at 1.8
KV, 400Ω, 25µFad. The electroporated cells were recovered in 2 ml BHI (0.5M sucrose)
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medium at 30°C for 2 h, and then were selected on BHI agar plates with 200 µg/ml
streptomycin and 5 µg/ml erythromycin at 30°C for 48 h. Transformants on the plates
were inoculated in 2 ml BHI medium with 5 µg/ml erythromycin and 10 µg/ml
kanamycin and incubated at 30°C overnight. 50 µl of the overnight culture was
transferred to a 10 ml BHI medium with 200 µg/ml streptomycin and 5 µg/ml
erythromycin and the incubation was continued at 30°C for 2 h, and then the incubation
temperature was shifted to 42°C to lose the plasmid on purpose and the incubation
continued for 6 h. 100 µl of the 1:100 diluted culture was directly plated on BHI agar
plates with 200 µg/ml streptomycin and 5 µg/ml erythromycin, and the transposon
mutants on these plates were grown at 42°C overnight.
Microtiter plate assay
The transposon mutants were grown in 200 µl BHI medium with 200 µg/ml
streptomycin and 5 µg/ml erythromycin in 96-well polystyrene plates at 37°C overnight
without shaking, and 5 µl of the overnight culture was transferred to 200 µl HTM
medium in 96-well polystyrene plates for biofilm growth at 37°C for 48 h without
shaking. For the biofilm test, the supernatant culture was discarded and each well was
washed with 250 µl PBS for 5 times. 210 µl of 1% crystal violet was added to each well
to stain the attached cells for 1 h, followed by distill water wash for 5 times. Then 220 µl
of 95% ethanol was added to each well and incubated at room temperature for 6 h. The
absorbance of the ethanol solution at 570 nm was measured using the MULTISCAN EX
plate reader (Thermo, PA, USA).
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Linkage test
U153 phage [115] was used for the transduction. First of all, transposon mutants
were grown in LB medium with 200 µg/ml streptomycin and 5 µg/ml erythromycin at
30°C until the OD.600 reached 0.2. U153 phage stock was diluted to 106~104 titration,
and 100 µl of diluted phage solution was mixed with 100 µl transposon mutants culture
and incubated at room temperature for 40 min. Then 3 ml LB soft agar (0.75% agar) was
mixed with each phage-bacterium mixture and poured onto LB agar plates with 10 mM
CaCl2 and 10 mM MgSO4, following by incubation at room temperature for 24 h.
The plaque layer of the LB agar plates was soaked in 1 ml TM buffer (10 mM Tris
HCl pH7.5, 10 mM MgSO4) for 25 min, then a sterile spreader was used to screw up the
plaque layer, and both the TM solution and pieces of plaque layer were collected in a
sterile centrifuge tube. The mixture was vortexed vigorously, and then centrifuged at
8000 rpm for 10 min. The supernatant was transferred to another sterile centrifuge tube,
mixed with 1/10 Volume of chloroform, and kept at room temperature for 10 min after
vigorous vortex. The supernatant was collected as the mutant phage stock.
100 µl of mutant phage stock was mixed with 200 µl L. monocytogenes 10403S
culture which was grown in LB medium at 30°C, and incubated at room temperature for
1 h. Then 3 ml BHI soft agar (0.75%) was mixed with the mixture and poured onto BHI
agar plates with 10 mM sodium citrate and 5 µg/ml erythromycin. Plates were incubated
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at 37°C for 2 h, and then another layer of BHI soft agar was added to the plates. The
incubation was continued at 37°C for 48 h. Colonies growing on the plates were
randomly selected for the biofilm test as previously described, and the biofilms of these
colonies were compared with the wild type 10403S and the original transposon mutants.
Probe preparation and southern blot
The probe for erythromycin resistance cassette in mariner transposon was
amplified using pMC38 plasmid as the template and primer # 88 and # 89. The resulting
PCR fragment was purified by QIAGEN QIAEX II purification kit. The purified product
was labeled with Biotin 3’ End DNA Labeling Kit (Pierce, IL, USA, PROD # 89818) as
follow: First of all 100 ng DNA probe was denatured by heating in boiling water for 5
min. Then 50 µl of reaction mixture, which contained 10 µl of 5ҳ TdT Reaction Buffer, 5
pmol final 3’-OH end of pre-denatured DNA probe, 5 µl of 5µM Biotin-11-UTP, 5 µl of
2 U/µl diluted TdT and ultrapure water, was prepared by adding individual components
to the same reaction tube. The mixture was incubated at 37°C for 30 min, and the reaction
was stopped by adding 2.5 µl of 0.2M EDTA. The labeled DNA probe was purified with
chloroform: isoamyl alcohol, heated at 100°C for 5 min and placed on ice for the
subsequent hybridization.
The genomic DNA of the L. monocytogenes transposon mutants were prepared
with Wizard genomic DNA isolation kit (Promega, WI, USA), and 5µg of genomic DNA
was digested with Hind III (TaKaRa, Japan) at 37°C overnight. Then the digested DNAs
were applied to 0.8% agarose gel and electrophoresed at 25 constant voltage for 10 hours.
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After electrophoresis, the gel was acid-depurinated by 0.25N HCl and denatured with
0.5M NaOH and 1.5M NaCl for 45min, then neutralized with 0.5M Tris and 1.5M NaCl
for 45min. DNA was transferred to positively charged nylon membrane (GE, Canada,
VCAT# NP0HYB0010) using a downward transfer apparatus. After transfering, DNA
was cross-linked to the membrane using the UVP CL-1000 Ultraviolet Crosslinker
(254nm, autosetting) (UVP, CA), and the membrane was incubated in pre-hybridization
buffer (6ҳ SSC, 5ҳ Denhardt solution, 0.5% SDS, 100µg/ml denatured fish sperm DNA)
at 55°C for 2 h. Then hybridization was performed using hybridization buffer (6ҳ SSC,
0.5% SDS) with labeled DNA probe (30 ng per ml of hybridization buffer) at 55°C
overnight. On the next day, the membrane was washed 3 times for 15 min per wash with
gentle agitation using the 50°C preheated wash buffer (2ҳ SSC, 0.1% SDS). Then the
signal was detected using Chemiluminescent Detection Kit (Pierce, IL, USA, PROD #
89880) according to the provided protocol.
Transposon localization
Arbitrary-Primed PCR, as described before[116], was utilized to identify the
location of the transposon on the chromosome. First round PCR was performed using
primer # 5 paired with # 7 or # 10 in a final volume of 25µl with fresh colony from BHI
plates and Choice Taq Polymerase (Denville, NJ, USA), and PCR was performed under
following conditions: 95°C for 2min; 25 cycles of 94°C for 30sec, 42°C for 45sec, 72°C
for 1min; and a final extension at 72°C for 5min. Then 5µl of the 1:25 dilution of the first
round PCR product was used as the template for the second round PCR. The second
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round PCR was performed using primer # 6 paired with # 8 or # 11 in a final volume of
25µl with Choice Taq Polymerase (Denville, NJ, USA) under the following conditions:
95°C for 2min; 25 cycles of 94°C for 30sec, 45°C for 45sec, 72°C for 1min; and a final
extension at 72°C for 5min. The amplified products were subjected to agarose gel (1%)
electrophoresis. Fragments from the agarose gel were excised and purified by QiaEXII
(Qiagen, Germany). The purified fragments were sent for sequencing (Genomic Institute,
Clemson University) using primer # 9 or # 12. The obtained sequences were blasted
using NCBI nucleotide blast program (http://blast.ncbi.nlm.nih.gov/BlastoCgi).
Construction of in-frame deletion mutant
Various sets of primers (#37~#40 for lmo1256; #41~#44 for lmo2553; #45~#48 for
lmo2554; #49~#52 for lmo1083) were used to amplify upstream fragment and
downstream fragment of target genes using genomic DNA of 10403S as the template
with High Fidelity Taq Polymerase (Roche, Switzerland) in a final volume of 25 µl. Then
1 µl of upstream and downtream fragments were mixed and used as template for the
Gene Splicing by Overlap Extension (gene SOEing)[117] as described before to generate
in-frame deletion fragment. The amplified product was subjected to agarose gel (0.8%)
electrophoresis, and purified by QiaEXII (Qiagen, Germany). The purified product was
digested with EcoR I and Hind III restriction enzymes (TaKaRa, Japan). After
purification with the QiaEXII (QIAGEN, Germany), the digested fragment was ligated
with the pKSV7 plasmid[19], which was digested with the same restriction enzymes and
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purified. E.coli DH5α competent cells were transformed with the ligation products and
selected for ampicillin resistance on LB plates.
High purity pKSV7-deleted fragment plasmids were isolated from the E. coli
transformants using PureYield Plasmid Miniprep System (Promega, WI, USA).
Electroporation was performed to transform the pKSV7-deleted fragment plasmids into
10403S competent cells at 1.8 KV, 400 Ω and 25 µFad. Transformants were selected for
chloramphenicol resistance on BHI agar plates. The integrants were selected by
incubation at 42°C in BHI plates supplemented with 10µg/ml chloramphenicol. The
plasmid containing the wild type copy of the corresponding gene after alleic exchange
was removed by passaging the bacterial culture in the BHI medium without
chloramphenicol at 30°C for 8~12 passages. The bacterial colonies spread on BHI plates
were randomly selected and tested for chloramphenicol sensitivity. Chloramphenicol
sensitive colonies were subjected to PCR using respective primers to confirm the deletion.
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Table 3-1. Strains used in this study.
Strains
E.coli

Genotype

References

-

DH5α
CE49
CE51
CE52
CE53
L.monocytogenes
10403S
NF-L943
TM-1
TM-2
TM-6
TM-16
TMY-95
TMY-169
TMY-235
TMY-386
TMY-408
TMY-423
TMY-438
TMY-486
TMY-489
TMY-521
CL-9
CL-10
CL-18
CL-19
CL-25
CL-35
CL-57
CL-59
CL-60
CL-61
CL-62
CL-63
CL-64

F endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG
-

+

Φ80dlacZ ΔM15 Δ(lacZYA-argF )U169, hsdR17(rK mK ), λ–
pKSV7-∆1083 in DH5α
pKSV7-∆2553 in DH5α
pKSV7-∆2554 in DH5α
pKSV7-∆1256 in DH5α

a streptomycin resistant isolate of strain 10403, 1/2a serotype
PrfA G155S mutation in 10403S background with
actA-gus-plc B transcriptional fusion
transposon insertion at lmo0644 in NF-L943 background
transposon insertion at lmo1262/lmo1263 in NF-L943 background
transposon insertion at lmo2553/lmo2554 in NF-L943 background
transposon insertion at lmo0707 in NF-L943 background
transposon insertion at lmo2205 in 10403S background
transposon insertion at lmo0734 in 10403S background
transposon insertion at lmo0106 in 10403S background
transposon insertion at lmo0086 in 10403S background
transposon insertion at lmo2534 in 10403S background
transposon insertion at lmo2535 in 10403S background
transposon insertion at lmo2529 in 10403S background
transposon insertion at lmo0676 in 10403S background
transposon insertion at lmo1370 in 10403S background
transposon insertion at lmo2229 in 10403S background
∆plcA and ∆plcB in 10403S
∆hly in 10403S
∆i nlB in 10403S
∆inlA in 10403S
∆mpl in 10403S
∆actA in 10403S
∆prfA in 10403S
∆lmo1083 in 10403S
∆lmo1256 in 10403S
∆lmo2554 in 10403S
∆lmo2553 in 10403S
∆lmo2553 in 10403S
∆flaA in 10403S
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lab stock
this study
this study
this study
this study

lab stock
28
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
118
119
120
120
121
122
123
this study
this study
this study
this study
this study
124

Table 3-2. Plasmids used in this study.

Plasmids
pMC38
pKSV7
pMC43
pMC45
pMC46
pMC47

Description
mariner transposon vector with Bsu PmrgA, ts ori
intergrational vector derived from pE194ts
in-frame deletion of lmo1083 in pKSV7
in-frame deletion of lmo2553 in pKSV7
in-frame deletion of lmo2554 in pKSV7
in-frame deletion of lmo1256 in pKSV7
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References
108
14
this study
this study
this study
this study

#

28

1
2
5
6
7
8
9
10
11
12
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52

Name
Marq112
Marq113
ARB1
ARB2
Marq 255
Marq 256
Marq 257
Marq 269
Marq 270
Marq 271
1256 up forward
1256 up reverse
1256 down forward
1256 down reverse
2553 up forward
2553 up reverse
2553 down forward
2553 down reverse
2554 up forward
2554 up reverse
2554 down forward
2554 down reverse
1083 up forward
1083 up reverse
1083 down forward
1083 down reverse

Sequences
Applications
FOR CHECKING AND SEQUENCING CLONES IN pKSV7
5'-CGC CAG GGT TTT CCC AGT CAC GAC-3'
FOR CHECKING AND SEQUENCING CLONES IN pKSV7
5'-AGC GGA TAA CAA TTT CAC ACA GGA-3'
ARBITRARY PRIMER 1 FOR NESTED PCR
5'-GGC CAC GCG TCG ACT AGT ACN NNN NNN NNN GTA AT-3'
ARBITRARY PRIMER 2 FOR NESTED PCR
5'-GGC CAC GCG TCG ACT AGT AC-3'
MARINER LEFT END PRIMER FOR 1ST ROUND NESTED PCR
5'-CAG TAC AAT CTG CTC TGA TGC CGC-3'
MARINER LEFT END PRIMER FOR 2ND ROUND NESTED PCR
5'-TAG TTA AGC CAG CCC CGA CAC CCG-3'
MARINER LEFT END PRIMER FOR SEQUENCING
5'-CTT ACA GAC AAG CTG TGA CCG TCT-3'
MARINER RIGHT END PRIMER FOR 1ST ROUND NESTED PCR
5'-GCT CTG ATA AAT ATG AAC ATG ATG-3'
MARINER RIGHT END PRIMER FOR 2ND ROUND NESTED PCR
5'-TGT GAA ATA CCG CAC AGA TGC GAA-3'
MARINER RIGHT END PRIMER FOR SEQUENCING
5'-GGG AAT CAT TTG AAG GTT GGT ACT-3'
FOR GENERATION OF lmo1256 IN FRAME DELETION
5'-GGA ATT CTT AGC ATC TAC TTT GGC ATC C-3'
FOR GENERATION OF lmo1256 IN FRAME DELETION
5'-GTA TTT TTA TGC TGT TTA TTG TTT CAT GCC CAT CTC TCC-3'
FOR GENERATION OF lmo1256 IN FRAME DELETION
5'-GGA GAG ATG GGC ATG AAA CAA TAA ACA GCA TAA AAA TAC-3'
FOR GENERATION OF lmo1256 IN FRAME DELETION
5'-CCC AAG CTT AAA AAT ACC GTA ACA AAG AGG-3'
FOR GENERATION OF lmo2553 IN FRAME DELETION
5'-GGA ATT CTG GGC AGG CGG ATT TTC TTT TGG T-3'
FOR GENERATION OF lmo2553 IN FRAME DELETION
5'-GAT TTT TTG GGA CGC TGT ATC TAC CTT TCA CTC CTT CGT TAA-3'
5'-TTA ACG AAG GAG TGA AAG GTA GAT ACA GCG TCC CAA AAA ATC-3' FOR GENERATION OF lmo2553 IN FRAME DELETION
FOR GENERATION OF lmo2553 IN FRAME DELETION
5'-AAC TGC AGC CTT CCA AGC ATA GCA CCC ATT AAA TA-3'
FOR GENERATION OF lmo2554 IN FRAME DELETION
5'-GGA ATT CGG GAT CTG TTT GTG AGT GC-3'
FOR GENERATION OF lmo2554 IN FRAME DELETION
5'-GCC TAA CCA TAT TTC AGC ACC CTG ACC TTT TAC TTT TTC-3'
FOR GENERATION OF lmo2554 IN FRAME DELETION
5'-GAA AAA GTA AAA GGT CAG GGT GCT GAA ATA TGG TTA GGC-3'
FOR GENERATION OF lmo2554 IN FRAME DELETION
5'-CCC AAG CTT ACT AAA AAG TTC AGC ACG ACC-3'
FOR GENERATION OF lmo1083 IN FRAME DELETION
5'-GCT CTA GAA TAA CCA CTC TCT TTC TGT G-3'
5'-GAT AGT TTC TTT AAT TCC TGT ATA AGT CAG CAA ATC TAA GTT TAC-3' FOR GENERATION OF lmo1083 IN FRAME DELETION
5'-GTA AAC TTA GAT TTG CTG ACT TAT ACA GGA ATT AAA GAA ACT ATC-3' FOR GENERATION OF lmo1083 IN FRAME DELETION
FOR GENERATION OF lmo1083 IN FRAME DELETION
5'-GGG GTA CCT TTT TTT CTA AAG CAA CT-3'

88

Marq254

5' - CGTGGAATACGGGTTTGCTAAAAG - 3'

89

Marq206

5' - TGTCAGACATATGGGCACACGAAAAACAAGT - 3'

INTERNAL OF ermC FOR AMPLIFICATION OF PROBE
FOR SOUTHERN BLOT
3'-END OF ermC FOR AMPLIFICATION OF PROBE
FOR SOUTHERN BLOT

References
14
14
108
108
108
108
108
108
108
108
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
108
108

CHAPTER FOUR
RESULTS
Optimization of biofilm growth conditions
In order to select the proper condition which can stimulate robust biofilm growth,
various combinations of medium and temperature were tested for their ability to promote
L. monocytogenes biofilm growth before the screening. After testing the wild type
10403S biofilm growth at 37°C and 30°C in either LB or HTM medium, 37°C and HTM,
minimal medium were finally selected as the standard conditions for the subsequent
microtiter plate assays, because bacteria had the most robust biofilm growth under these
conditions. As shown in Figure 4-1, regardless of the temperature, HTM medium
promotes better biofilm growth than LB medium, while 37°C is better than 30°C no
matter which medium was used.
Selection of biofilm abnormal mutants
A total of 10,000 mutants were generated through transposon mutagenesis. The
biofilm formation ability of these mutants were compared with the wild type 10403S
strain and the flaA in-frame deletion mutant in HTM, the minimal medium in 96-well
polystyrene plates. Under our test conditions, the OD.570 of the 10403S biofilm after 48
h incubation generally was around 1.40, while the OD.570 of flaA mutant was around
0.70. 14 mutants were selected for at least 50% decrease biofilm formation compared
with the 10403S, and biofilm formation of 4 mutants were shown in Figure 4-2. The
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growth rates of these 14 mutants were studied in both BHI and HTM medium, and none
of them showed any growth defect compared with the wild type 10403S. Southernblot
revealed the single transposon insertion in these mutants, and linkage test showed that the
biofilm defects of these mutants indeed linked with the transposon insertion.
Identification of transposon locations
By arbitrary-primed PCR and sequence analysis in NCBI Nucleotide data base, the
transposon location in these 14 mutants were successfully identified. In some mutants the
transposon inserted in the open reading frame of genes, while in others it located between
adjacent open reading frames. The transposon location in 3 mutants were shown in Figure
4-3,4-4, 4-5 and the descriptions of these genes were summarized in Table 4-1.
The role of lmo1083, lmo1256, lmo2553 & lmo2554 in biofilm formation
In Tm-6 mutant, the transposon located at the end of the open reading frame of the
gene lmo2554 between 916 bp and 917 bp. Because there are only 6 bp between the open
reading frame of the gene lmo2554 and lmo2553, this transposon insertion probably
would affect the transcription of both lmo2554 and lmo2553 since these two genes are
normally co-transcribed. Thus in-frame deletion mutant of both genes were constructed,
and tested for biofilm growth in polystyrene tubes. In HTM medium, a reproducible
defect compared with the wild type was observed among all the three time points tested
with ∆lmo2554 strain (Figure 4-7), with a 87% decrease at 24 h, a 96% decrease at 48 h
and 72 h. Biofilm of ∆lmo2553 strain decreased as well, with a 84% reduction at 24 h, a
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75% reduction at 48 h and 72 h (Figure 4-7). To collect the biofilm growth information
from different medium, biofilm growth of constructed deletion mutants were also tested
in LB medium. In LB medium biofilm of ∆lmo2554 strain had a 70% decrease at 24 h
and 72 h, and a 53% decrease at 48 h compared with the wild type (Figure 4-6), while
biofilm of the ∆lmo2553 strain had about a 45% reduction at 24 h, 48 h and 72 h (Figure
4-6).
In addition to these two, in-frame deletion mutant of other two genes, lmo1083
encoding a protein similar to dTDP-D-glucose 4,6-dehydratase, and lmo1256 encoding a
hypothetical protein, were also constructed. These two genes were identified from other
project. Biofilm test of these two mutants were performed with HTM and LB medium.
Interestingly ∆lmo1083 strain had a similar biofilm growth pattern as the wild type in
HTM medium (Figure 4-7), while in LB medium the absence of lmo1083 led to a 77%
decrease at 24 h, a 37% decrease at 48 h and a 51% decrease at 72 h (Figure 4-6).
Absence of lmo1256 did not affect the biofilm formation in LB or HTM medium. Thus
lmo1083 might also play a role in L. monocytogenes biofilm formation, and this effect
might relate to the specific medium used.
PrfA and virulence genes in biofilm
Biofilm of the PrfA mutant and other virulence genes mutants were also compared
with the wild type strain 10403S in LB and HTM medium. As shown in Figure 4-8, the
absence of PrfA and other virulence genes had a minimal effect on biofilm growth in LB.
But in HTM medium (Figure 4-9), deletion of PrfA led to a 70% biofilm reduction at 24
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h, and a 40% reduction at both 48 h and 72 h. Most of the tested virulence mutants had a
similar biofilm level as the wild type, except for the plcA- plcB- double mutant and mplmutant (Figure 4-9). Absence of plcA and plcB resulted in a similar 40% biofilm
reduction as that of the prfA- mutant at 48 h and 72 h, but only minimal decrease was
observed at 24 h. A 50%, 66%, and 80% decrease at 24 h, 48 h and 72 h respectively was
observed for the mpl- mutant.
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biofilm condition test
2.500

OD.570

2.000
24 H

1.500

48 H

1.000

72 H

0.500
0.000
37℃ LB

37℃ HTM

30℃ LB

30℃HTM

conditions

Figure 4-1. Average biofilm growth of the wild type 10403S strain from 3 parallel repeats
in LB and HTM medium in 96-well polystyrene plates at 37°C and 30°C after different
incubation periods.
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3 day biofilm
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1.500
1.000

48h

0.500

72h

0.000
NF-L943 10403S

∆flaA

TM-1
strains

TM-2

TM-6

TM-16

Figure 4-2. Average 3-day biofilm formation of several transposon mutants from 3
parallel repeats in HTM medium in 96-well polystyrene plates.
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Figure 4-3. Transposon location in mutant TM-2, which led to the identification of the
genes lmo1262 and lmo1263. The symbol represents the terminator. The symbol
represents the location of the transposon, and the direction represents the orientation of
the erythromycin resistance cassette in the transposon.
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Figure 4-4. Transposon location in mutant TM-6, which led to the identification of the
genes lmo2553 and lmo2554. The symbol represents the terminator. The symbol
represents the location of the transposon, and the direction represents the orientation of
the erythromycin resistance cassette in the transposon.
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Figure 4-5. Transposon location in mutant TM-16, which led to the identification of the
gene lmo0707. The symbol represents the terminator. The symbol
represents the
location of the transposon, and the direction represents the orientation of the
erythromycin resistance cassette in the transposon.
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Table 4-1. Identified genes through transposon localization in this study.

Gene
lmo0734
lmo1262
lmo1263
lmo2553
lmo2554
lmo0106
lmo0644
lmo1370
lmo2229
lmo2205
lmo0086
lmo2534
lmo2535
lmo2529
lmo0685
lmo0707

Description
Similar to transcriptional regulator (LacI family)
similar to transcriptional regulator(phage-related)
similar to transcriptional regulator
hypothetical protein
similar to galactosyltransferase
DltD protein for D-alanine esterification of lipoteichoic
LTA synthesis, Transfer initial glycerolphosphate to form
dGroP-Gal-Glc-DAG

48 h Defect
3.1
4
4
5.6
5.6
7.6

Similar to branched chain fatty acid kinase
Similar to penicillian- binding protein
Similar to phosphoglyceromutase1
Phosphoribosylformylglycinamidine synthetase I
AtpE
AtpB
AtpD
Flagella biosysthesis protein
Flagellar FliD

50
5.4
3.6
17.9
12.2
14.9
4.4
4.8
2
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Figure 4-6. Average biofilm formation of the in-frame deletion mutants from 3 parallel
repeats in LB medium in polystyrene tubes compared with the wild type 10403s and
∆flaA strain.
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Figure 4-7. Average biofilm formation of the in-frame deletion mutants from 3 parallel
repeats in HTM medium in polystyrene tubes compared with the wild type 10403s and
∆flaA strain.
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Figure 4-8. Average biofilm formation of the PrfA mutant and virulence mutants from 3
parallel repeats in LB medium in polystyrene tubes compared with the wild type 10403s
strain.
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Figure 4-9. Average biofilm formation of the PrfA mutant and virulence mutants from 3
parallel repeats in HTM medium in polystyrene tubes compared with the wild type
10403s strain.
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CHAPTER FIVE
DISCUSSION
The adapted ability of biofilm formation can dramatically facilitate the bacterial
transmission and infection. L. monocytogenes has been demonstrated to be capable of
biofilm growth, which definitely increases its survival opportunity and chances to cause
serious infections. Although several groups have identified a few functional
molecules[52,57,73] that play critical roles in L. monocytogenes biofilm development,
transcriptomic[125,126] and proteomic[127-129] studies on other species have also been
carried out to generate comprehensive views of this process. It’s a very complicated
phenomenon affected by so many factors that currently a well-understood network is still
lacking. In this study, a genome-wide screening for the functional factors involved in L.
monocytogenes biofilm was performed through mariner transposon mutagenesis in
combination with microtiter plate assays. The mariner transposon was initially
constructed based on Himar 1 mariner, and modified specially for the transposition in
low GC content Gram-positive microorganisms[114] with advantages including high
transposition efficiency, good randomness, and low plasmid retention rate[114]. From
10,000 mutants screened, 14 were selected for an at least 50% reproducible biofilm
defects comparing with the wild type. The growth rate of these 14 mutants was compared
with the wild type, and none of them showed any growth defect, excluding the possibility
of impaired growth of these mutants in our tests. The linkage test results suggested that
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the transposon insertion in the bacterial chromosome is responsible for the observed
biofilm defects.
The transposon insertion site in the 14 mutants were identified, and the genes
involved were categorized into 5 different functional groups as shown in table 3-1,
including transcriptional regulation, bacterial cell wall synthesis, flagella assembly, ATP
formation and metabolism.
A big group of genes we’ve identified relates to cell wall components biosynthesis,
especially lipoteichoic acid (LTA). LTA is a secondary wall polymer that consists of the
cell wall of Gram positive bacteria with peptidoglycan, proteins, and capsular
polysaccharides[130]. Normally LTA has a basic structure in which a polyglycerolphosphate chain linked with the membrane glycolipid[131]. It is known that the
glycerolphosphate in L. monocytogenes could be substituted by glycosyl residues or Dalanine esters[131]. LTA is a macroamphiphile molecule which by its electric charge
properties exerts several functions in the Gram positive bacteria, including protection
against environmental stress[132], regulation of cation concentration in the cell wall[133],
and interaction with host cells[134], while D-alanylation of LTA directly relates to the
electric charge properties of this polymer. LTA is an anionic polymer, and the D-alanine
ester formation requires the anionic glycerolphosphate group and the cationic D-alanine
group. The D-alanine ester content was suggested to determine the number of available
anionic sites on LTA for binding with other cationic substances[133], such as autolysins,
the enzymes catalyzing the hydrolysis of covalent bonds in the peptidoglycan of cell
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wall[135]. So it seems like without functional D-alanine ester more autolysins would be
able to bind to the LTA, and result in increased autolysis. This idea possibly explains the
identification of the gene lmo0106 in our study. lmo0106 encodes the DltD protein for Dalanine esterification of LTA. It’s reasonable that insertion mutation of DltD jeopardized
the D-alanine ester substitution of LTA, which subsequently led to increased autolysins
binding to the LTA in the mutant, increased cell lysis and reduced cell number in the
biofilm community. A similar autolysis up-regulation was observed in Lactobacillus
rhamnosus D-alanylation mutant[133].
Other genes in this group include lmo1370 encoding a branched chain fatty acid
kinase that transfers a phosphate group from the ATP to 2-methylpropanoate, lmo2229
encoding a penicillin-binding protein which is involved in peptidoglycan biosynthesis,
lmo2553 encoding a hypothetical protein, lmo2554 encoding a galactosyltransferase
which is responsible for the glycolipid anchor production of LTA[131], and lmo0644
encoding the LTA primase that mediates the transfer of initial glycerolphosphate to the
glycolipid [131]. Huebner’s group recently discovered that the glycolipids of
Enterococcus

faecalis

is

involved

in

biofilm

formation[136].

The

putative

glucosyltransferase mutant exhibited significant alteration of membrane glycolipid profile
and failed to accumulate in growing biofilm, although the initial adhesion was not
affected[136]. LTA synthesis was proven to be required for S.aureus growth at
37°C[137], and the destruction of polyglycerolphosphate synthase resulted in aberrant
cell division and separation[137]. In our study, it seems like the LTA is required for L.
monocytogenes biofilm formation. In-frame deletion of lmo2554 resulted in a around 90%
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biofilm reduction while in-frame deletion of lmo2553 led to a around 80% biofilm
reduction at 37°C in HTM medium. In LB medium the biofilm reduction effect due to the
absence of these two genes was not as significant as in HTM medium. To further support
the role of cell wall components in L. monocytogenes biofilm, deletion mutants of the
other identified genes should be tested for biofilm growth, and the respective genetic
complementation should be performed as well to confirm their involvements.
Three transcriptional regulators were identified in our test. In the TM-1 transposon
mutant, the transposon located at the 150 bp intergenic region between lmo1262 and
lmo1263. The transposon inserted between 32 bp and 33 bp upstream of lmo1262. It’s
possible that this insertion probably affected the promoter function and the subsequent
transcription of both genes. lmo1262 encodes a phage-related transcriptional regulator.
Bioinformatic analysis of the protein sequence indicates that it is a phage λ repressor-like
DNA binding protein. λ repressor DNA binding protein controls the expression of viral
genes involved in lysogeny/lytic growth switch. This type of repressor is essential for
maintaining the lysogeny cycle, and lytic growth is only induced when the host cell is
threatened. It usually contains two domains connected by a linker: an N-terminal DNAbinding domain which also mediates the interaction with RNA polymerase, and a Cterminal dimerisation domain. The HTH motif of Lmo1262 locates at the N-terminal
from 5th to 63rd amino acid. Analysis of lmo1263 suggests that it also encodes a HTHXRE transcriptional regulator, but is not phage-related. The HTH motif locates from 13th
amino acid to 69th amino acid. lmo0734 encodes a PurR transcriptional regulator, the Nterminal of which contains a HTH binding domain of Lac I family transcriptional
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regulator. It was well proved that PurR and Lac I family transcriptional regulators have
highly homologous secondary and tertiary structure[138]. This probably implies that the
Lmo0734 regulator binds to DNA via its N-terminal domains to repress downstream gene
transcription, and this repression can be retrieved through the interaction with a small
effector ligand in a cleft of core N- and C-terminal intermediate region. The identification
of the downstream genes regulated by these transcriptional regulators will reveal more
valuable information about the underlying mechanisms of L. monocytogenes biofilm.
Chromatin immune-precipitation (CHIP) based on the affinitive interaction between
transcriptional regulator and its antibody could be a good method to pursue for this
purpose.
Flagellum is a tail-like structure protruding from the cell body that generally
mediates the bacterial extracellular movement. Flagellum biosynthesis plays an important
role in L. monocytogenes extracellular motility, and several groups have reported
different roles of flagellum in L. monocytogenes biofilm development. Though flagellum
was generally considered as essential during the whole biofilm developmental
process[52], Young’s group did provide different evidences supporting the idea that
flagellum was only required for the initial cell attachment, and absence of flagellum led
to a final increased biofilm growth[53]. The two genes identified in our study actually
function in different aspects of flagellum. lmo0685 encodes a flagellum biosynthesis
protein similar to MotA, which with MotB together forms the ion channels that couple
flagellar rotation to the proton motive force across the membrane[139]. MotA mutation
should destroy the ion channels to some extent and probably cut off the rotor power for
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flagella rotations. Identification of this gene indicates that flagellar motility might be
required for L. monocytogenes biofilm growth in our conditions. The other gene lmo0707
encodes the flagellar hook-associated protein FliD. This protein contributes to the flagella
functions by facilitating the polymerization of the flagellin monomers at the tip of
growing flagellum filament. FliD forms a cap-like structure, which prevents the flagellin
subunits from slipping out without polymerization at the end. Thus destroying the FliD
was expected to jeopardize the formation of regular flagellum tail. It seems like the
flagella tail-like structure is also involved in L. monocytogenes biofilm growth. It was
well documented that flagellum biosynthesis is dramatically shut down when the
bacterium senses the intracellular signal, such as 37°C which is the normal human body
temperature. Initially in this study various biofilm growth conditions were tested for
selection of optimal combination for biofilm growth, and 37°C reproducibly yielded
better biofilm growth than 30°C. This probably suggests that a tiny amount of flagellum
is enough for biofilm growth in our test condition.
lmo2205 which encodes a protein similar to phosphoglyceromutase 1 was
identified in our screening. Phosphoglyceromutase catalyzes the inter-conversion of 2phosphoglycerate and 3-phosphoglycerate, and it’s generally involved in carbohydrate
degradation and glycolysis. Another identified gene is lmo0086, which encodes the
phosphoribosylformylglycinamidine synthetase I. This enzyme catalyze the production of
ADP, phosphate, 2-(formamido)-N(1)-(5-phospho-D-ribosyl) acetamidine, and Lglutamate from a combination of substrates including ATP, N(2)-formyl-N(1)-(5phospho-D-ribosyl) glycinamide, L-glutamine and H2O. lmo1083 encoding a dTDP-D-
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glucose 4,6-dehydratase was identified in other project, and was found to involve in
biofilm formation in LB medium, since absence of this gene led to reduced biofilm in LB
medium, but not in HTM medium. It’s possible that some ingredients from the LB
complex medium specifically influence the sugar metabolism, and require the dTDP-Dglucose 4,6-dehydratase to assume a normal biofilm development. More information is
needed to further characterize the role of these three genes in biofilm formation,
considering that carbohydrate metabolism could possibly affect several aspects, such as
bacterial physiology and matrix production, which could be relevant to normal biofilm
growth.
Another group of genes identified in our screening includes lmo2534, lmo2535 and
lmo2529, all of which encode a subunit of ATP synthase. ATP is the primary energy
supplier for most physiological and biochemical activities. Thus blocking ATP
biosynthesis could interfere a lot of biological functions, including biofilm formation. It’s
noteworthy that the transposon mutants from this group did not show any growth defect.
This might be due to the redundant functions of other subunits in the ATP synthase.
Interestingly in our screening, we haven’t identified any increased biofilm mutant.
Neither did we find any gene previously proven to mediate L. monocytogenes biofilm.
Our bioinformatic study indicated that there are some homologues of B. subtilis proteins
which have been shown to regulate biofilm, such as lmo0168 that shares 60% identity
with the AbrB repressor, or lmo0806 that shares 35% identity with SinR repressor. No
such homologue was turned up during our screening either. One possible reason for this
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flaw is that among the 10,000 mutants we have screened several could be siblings, thus
we actually need to screen more mutants to fully cover the whole genome of L.
monocytogenes. The test conditions we adopted could be another possible reason.
Biofilm formation is the type of microbial activity that closely relates with its
surrounding environment. A minor variation in the test condition could lead to big
differences in the results. The third possibility is that those essential genes which might
also affect biofilm formation would not be found in our screening due to the limits of the
method we used.
It was recently reported that besides mediating the transition from an extracellular
free-living style to an intracellular pathogen, the master regulator of L. monocytogenes
virulence, PrfA also contributes to normal biofilm growth[41]. Besides the genome-wide
screening for functional factors in L. monocytogenes biofilm, we also tried to probe the
role of PrfA in biofilm. Consistent with the reported result, deletion of PrfA led to a
dramatic reduction in biofilm formation in minimal medium, while constitutive
expression of PrfA had minimal effect. Surprisingly different from the reported, two
virulence mutants, plcA-plcB- double deletion mutant and mpl mutant, showed obvious
biofilm defects in our study. The biofilm reduction for plcA-plcB- double mutant was
similar to that of the PrfA mutant at 48 h and 72 h, while the reduction of mpl mutant was
even more significant than that of the PrfA and double mutant. It would be interesting to
investigate whether the contribution of PrfA in biofilm is related with its regulatory effect
on the virulence genes, or other unidentified factors. mpl encodes the zinc
metalloprotease which is responsible for the maturation of the broad-range phospholipase
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C (PC-PLC) encoded by plcB. It contributes to L. monocytogenes virulence by cleaving
the N-terminal signal peptide of PC-PLC. This cleavage activates the PC-PLC enzyme
activity that is important for bacterial escape from the vacuole. If Mpl contributes to
biofilm growth only by function of PC-PLC, a similar defect of mpl- mutant and plcBmutant would be expected. However the variation between our mpl- mutant and plcAplcB- double mutant seems to indicate that Mpl might have another downstream target,
and this target also plays a role in biofilm growth. It will be more valid to compare the
biofilm formation of plcB- mutant with mpl- mutant. Also it will be interesting to look at
whether the enzyme activity of PC-PLC is required for biofilm or not.
In conclusion, we identified 16 genes that are possibly involved in L.
monocytogenes biofilm formation by transposon mutagenesis in combination with
microtiter plate assay. These genes play a role in bacterial transcriptional regulation, cell
wall synthesis, flagella assembly, ATP formation or metabolism. The detailed functions
of these genes in biofilm development await further study through the non-polar mutants
and the signal pathways involved. This study will generate several valuable information
about the molecular basis of L. monocytogenes biofilm formation, which will eventually
help with the identification and development of drug targets for biofilm eradication.
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